VIGL Insider Trading
Insider Ownership Percentage: 33.03%
Insider Buying (Last 12 Months): $40,570.00
Insider Selling (Last 12 Months): $0.00
Vigil Neuroscience Share Price & Price History
Current Price: $2.02
Price Change: ▼ Price Decrease of -0.09 (-4.27%)
As of 03/14/2025 05:00 PM ET
Vigil Neuroscience Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
12/19/2024 | Haeberlein Samantha L Budd | Director | Buy | 12,000 | $1.71 | $20,520.00 | 12,000 | |
12/18/2024 | Ivana Magovcevic-Liebisch | CEO | Buy | 5,000 | $1.67 | $8,350.00 | 217,687 | |
12/5/2024 | Ivana Magovcevic-Liebisch | CEO | Buy | 5,000 | $2.34 | $11,700.00 | 212,687 | |
11/20/2023 | Ivana Magovcevic-Liebisch | CEO | Buy | 4,000 | $3.75 | $15,000.00 | 207,687 | |
11/18/2022 | Spyros Papapetropoulos | Insider | Sell | 300 | $14.00 | $4,200.00 | 4,000 | |
5/16/2022 | Clay Thorp | Director | Buy | 21,802 | $2.76 | $60,173.52 | 1,541,137 | |
5/5/2022 | Evan Thackaberry | SVP | Buy | 1,500 | $4.00 | $6,000.00 | 1,500 | |
5/3/2022 | Christopher Verni | General Counsel | Buy | 4,000 | $3.77 | $15,080.00 | 4,000 | |
5/3/2022 | Ivana Magovcevic-Liebisch | CEO | Buy | 1,000 | $3.94 | $3,940.00 | 203,687 | |
3/28/2022 | Clay Thorp | Director | Buy | 3,000 | $7.20 | $21,600.00 | | |
Vigil Neuroscience Institutional Trading History
Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
---|
2/17/2025 | Woodline Partners LP | 488,756 | $0.83M | 0.0% | +239.1% | 1.196% |  |
2/17/2025 | Squarepoint Ops LLC | 113,596 | $0.19M | 0.0% | N/A | 0.278% |  |
2/17/2025 | Two Sigma Advisers LP | 69,100 | $0.12M | 0.0% | +243.8% | 0.169% |  |
2/17/2025 | Two Sigma Investments LP | 136,920 | $0.23M | 0.0% | +44.0% | 0.335% |  |
2/17/2025 | Trustees of Columbia University in the City of New York | 192,973 | $0.33M | 0.1% | N/A | 0.472% |  |
2/17/2025 | Sphera Funds Management LTD. | 1,502,429 | $2.55M | 0.5% | -8.8% | 3.675% |  |
2/17/2025 | Point72 Asset Management L.P. | 250,000 | $0.43M | 0.0% | -84.4% | 0.612% |  |
2/17/2025 | Millennium Management LLC | 343,814 | $0.58M | 0.0% | +23.3% | 0.841% |  |
2/17/2025 | Ensign Peak Advisors Inc | 703,116 | $1.20M | 0.0% | +16.1% | 1.720% |  |
2/17/2025 | Cubist Systematic Strategies LLC | 24,120 | $41K | 0.0% | +53.0% | 0.059% |  |
2/17/2025 | Bridgeway Capital Management LLC | 100,064 | $0.17M | 0.0% | -4.8% | 0.245% |  |
2/17/2025 | 683 Capital Management LLC | 1,400,000 | $2.38M | 0.1% | +14.8% | 3.425% |  |
2/14/2025 | Jane Street Group LLC | 48,812 | $83K | 0.0% | N/A | 0.119% |  |
2/14/2025 | Northern Trust Corp | 64,737 | $0.11M | 0.0% | +29.0% | 0.158% |  |
2/14/2025 | Boothbay Fund Management LLC | 146,750 | $0.25M | 0.0% | N/A | 0.359% |  |
2/13/2025 | Marshall Wace LLP | 266,895 | $0.45M | 0.0% | +85.3% | 0.653% |  |
2/13/2025 | Barclays PLC | 64,049 | $0.11M | 0.0% | +43.6% | 0.157% |  |
2/13/2025 | Renaissance Technologies LLC | 367,300 | $0.62M | 0.0% | +698.5% | 0.898% |  |
2/13/2025 | ADAR1 Capital Management LLC | 15,543 | $26K | 0.0% | -28.5% | 0.038% |  |
2/12/2025 | Blair William & Co. IL | 323,900 | $0.55M | 0.0% | N/A | 0.792% |  |
1/24/2025 | abrdn plc | 528,472 | $0.90M | 0.0% | +124.9% | 1.293% |  |
11/16/2024 | Geode Capital Management LLC | 226,083 | $0.77M | 0.0% | +41.9% | 0.553% |  |
11/15/2024 | Sphera Funds Management LTD. | 1,647,604 | $5.60M | 0.9% | -2.6% | 4.030% |  |
11/15/2024 | Point72 Asset Management L.P. | 1,600,000 | $5.44M | 0.0% | +7.7% | 3.914% |  |
11/15/2024 | Point72 Asia Singapore Pte. Ltd. | 11,687 | $40K | 0.0% | -46.5% | 0.029% |  |
11/14/2024 | Verition Fund Management LLC | 130,030 | $0.44M | 0.0% | N/A | 0.318% |  |
11/14/2024 | Walleye Capital LLC | 119,792 | $0.41M | 0.0% | +334.4% | 0.293% |  |
10/25/2024 | abrdn plc | 235,011 | $0.80M | 0.0% | N/A | 0.593% |  |
9/16/2024 | Point72 Asia Singapore Pte. Ltd. | 21,854 | $87K | 0.0% | N/A | 0.058% |  |
8/19/2024 | Point72 Asset Management L.P. | 1,485,000 | $5.94M | 0.0% | N/A | 3.951% |  |
8/15/2024 | Point72 Asia Singapore Pte. Ltd. | 21,854 | $87K | 0.0% | N/A | 0.058% |  |
8/13/2024 | Ensign Peak Advisors Inc | 395,116 | $1.58M | 0.0% | +72.8% | 1.051% |  |
8/9/2024 | Renaissance Technologies LLC | 71,500 | $0.29M | 0.0% | +19.2% | 0.190% |  |
8/6/2024 | Acadian Asset Management LLC | 6,598 | $26K | 0.0% | N/A | 0.018% |  |
5/10/2024 | Vanguard Group Inc. | 894,473 | $3.05M | 0.0% | +11.9% | 2.380% |  |
1/30/2024 | Strs Ohio | 8,200 | $27K | 0.0% | N/A | 0.023% |  |
12/6/2023 | Citigroup Inc. | 64,303 | $0.35M | 0.0% | -6.9% | 0.179% |  |
11/15/2023 | Laurion Capital Management LP | 10,839 | $58K | 0.0% | -89.1% | 0.030% |  |
11/14/2023 | Deerfield Management Company L.P. Series C | 1,827,400 | $9.85M | 0.2% | -10.9% | 5.093% |  |
11/14/2023 | PEAK6 Investments LLC | 23,796 | $0.13M | 0.0% | +66.0% | 0.066% |  |
8/14/2023 | Deep Track Capital LP | 1,773,409 | $16.67M | 0.8% | -12.4% | 4.944% |  |
8/11/2023 | Artal Group S.A. | 1,911,191 | $17.97M | 0.6% | -14.8% | 5.328% |  |
8/4/2023 | American International Group Inc. | 7,734 | $73K | 0.0% | N/A | 0.022% |  |
8/2/2023 | Bank of Montreal Can | 73,243 | $0.73M | 0.0% | N/A | 0.205% |  |
5/4/2023 | Barclays PLC | 104,248 | $1.02M | 0.0% | -1.6% | 0.292% |  |
2/14/2023 | 683 Capital Management LLC | 15,092 | $0.19M | 0.0% | N/A | 0.042% |  |
2/13/2023 | Artal Group S.A. | 2,243,352 | $28.04M | 1.6% | -1.8% | 6.305% |  |
2/9/2023 | Citigroup Inc. | 93,927 | $1.17M | 0.0% | +38.8% | 0.264% |  |
2/1/2023 | Bank of Montreal Can | 58,100 | $0.73M | 0.0% | N/A | 0.163% |  |
11/15/2022 | BVF Inc. IL | 1,813,633 | $16.50M | 0.7% | N/A | 5.097% |  |
11/15/2022 | Citadel Advisors LLC | 2,166,467 | $19.72M | 0.0% | +0.1% | 6.089% |  |
11/14/2022 | Ergoteles LLC | 28,533 | $0.26M | 0.0% | N/A | 0.101% |  |
11/14/2022 | Altium Capital Management LP | 15,788 | $0.14M | 0.1% | N/A | 0.056% |  |
8/15/2022 | Laurion Capital Management LP | 130,200 | $0.34M | 0.0% | N/A | 0.461% |  |
5/16/2022 | Deep Track Capital LP | 389,141 | $2.74M | 0.2% | N/A | 1.377% |  |
5/12/2022 | Artal Group S.A. | 1,121,191 | $7.88M | 0.3% | N/A | 3.966% |  |
5/5/2022 | New York State Common Retirement Fund | 8,500 | $60K | 0.0% | N/A | 0.030% |  |
Data available starting January 2016
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.
Read More on Vigil Neuroscience
Volume
78,341 shs
Average Volume
470,477 shs
Market Capitalization
$82.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.82
Who are the company insiders with the largest holdings of Vigil Neuroscience?
Who are the major institutional investors of Vigil Neuroscience?
Which major investors are selling Vigil Neuroscience stock?
In the previous quarter, VIGL stock was sold by these institutional investors:
- Point72 Asset Management L.P.
- Sphera Funds Management LTD.
- ADAR1 Capital Management LLC
- Bridgeway Capital Management LLC
Which major investors are buying Vigil Neuroscience stock?
Within the previous quarter, VIGL stock was bought by institutional investors including:
- Woodline Partners LP
- Blair William & Co. IL
- Renaissance Technologies LLC
- abrdn plc
- Trustees of Columbia University in the City of New York
- 683 Capital Management LLC
- Boothbay Fund Management LLC
- Marshall Wace LLP
Within the last year, these company insiders have bought Vigil Neuroscience stock:
- Ivana Magovcevic-Liebisch (CEO)
- Haeberlein Samantha L Budd (Director)
Learn More investors buying Vigil Neuroscience stock.